Search Results - "Renlund, H"

Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease by Nordanstig, Joakim, James, Stefan, Andersson, Manne, Andersson, Mattias, Danielsson, Peter, Gillgren, Peter, Delle, Martin, Engström, Jan, Fransson, Torbjörn, Hamoud, Maher, Hilbertson, Anna, Johansson, Patrik, Karlsson, Lars, Kragsterman, Björn, Lindgren, Hans, Ludwigs, Karin, Mellander, Stefan, Nyman, Niklas, Renlund, Henrik, Sigvant, Birgitta, Skoog, Per, Starck, Joachim, Tegler, Gustaf, Toivola, Asko, Truedson, Maria, Wahlgren, Carl-Magnus, Wallinder, Jonas, Öjersjö, Andreas, Falkenberg, Mårten

“…Patients with peripheral artery disease were randomly assigned to receive endovascular intervention with paclitaxel-coated or uncoated devices. In an unplanned…”
Get full text

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry by Sahlén, Anders, Varenhorst, Christoph, Lagerqvist, Bo, Renlund, Henrik, Omerovic, Elmir, Erlinge, David, Wallentin, Lars, James, Stefan K, Jernberg, Tomas

“…Ticagrelor reduces ischaemic events and mortality in acute coronary syndrome (ACS) vs. clopidogrel. We wished to study clinical outcomes in a large real-world…”
Get full text

Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation by Jansson, M., Själander, S., Sjögren, V., Renlund, H., Norrving, B., Själander, A.

“…Direct oral anticoagulants (DOACs) have been proven non-inferior or superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major…”
Get full text

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation by Jansson, M., Själander, S., Sjögren, V., Björck, F., Renlund, H., Norrving, B., Själander, A.

“…Direct oral anticoagulants (DOACs) used in nonvalvular atrial fibrillation (NVAF) are dose-reduced in elderly and patients with impaired renal function. Only…”
Get full text

No significant difference in long-term symptoms after intraoperative gallbladder perforation with gallstones left in the abdomen by Edergren, Å., Sandblom, G., Renlund, H., Jaafar, G.

Get full text

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study by Schubert, Jessica, Lindahl, Bertil, Melhus, Håkan, Renlund, Henrik, Leosdottir, Margrét, Yari, Ali, Ueda, Peter, James, Stefan, Reading, Stephanie R, Dluzniewski, Paul J, Hamer, Andrew W, Jernberg, Tomas, Hagström, Emil

“…Abstract Aims  Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has,…”
Get full text

Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula by Sjögren, Vilhelm, Grzymala-Lubanski, Bartosz, Renlund, Henrik, Friberg, Leif, Lip, Gregory Y H, Svensson, Peter J, Själander, Anders

“…The safety and efficacy of warfarin in a large, unselected cohort of warfarin-treated patients with high quality of care is comparable to that reported for…”
Get more information

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction by Böhm, Felix, Mogensen, Brynjölfur, Engstrøm, Thomas, Stankovic, Goran, Srdanovic, Ilija, Lønborg, Jacob, Zwackman, Sammy, Hamid, Mehmet, Kellerth, Thomas, Lauermann, Jörg, Kajander, Olli A., Andersson, Jonas, Linder, Rikard, Angerås, Oskar, Renlund, Henrik, Ērglis, Andrejs, Menon, Madhav, Schultz, Carl, Laine, Mika, Held, Claes, Rück, Andreas, Östlund, Ollie, James, Stefan

“…In a registry-based trial, FFR-guided PCI of nonculprit lesions did not result in a lower risk of a composite of death from any cause, myocardial infarction,…”
Get full text

Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction by Schubert, Jessica, Lindahl, Bertil, Melhus, Håkan, Renlund, Henrik, Leosdottir, Margrét, Yari, Ali, Ueda, Peter, Jernberg, Tomas, Hagström, Emil

“…The incidence of atherosclerotic cardiovascular disease increases with levels of low-density lipoprotein cholesterol (LDL-C). Yet, a paradox may exist where…”
Get full text

5130Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality - a nationwide cohort study by Schubert, J, Lindahl, B, Melhus, H, Renlund, H, Leosdottir, M, Allahyari, A, Ueda, P, Jernberg, T, Hagstrom, E

“…Abstract Background In clinical trials, patients with myocardial infarction (MI) and elevated LDL-cholesterol (LDL-C) benefit the most from lipid lowering…”
Get full text

P5325A possible paradoxical association between LDL-cholesterol in myocardial infarction patients and relation to major adverse outcomes - a 10-year nationwide cohort study by Schubert, J, Lindahl, B, Melhus, H, Renlund, H, Leosdottir, M, Allahyari, A, Ueda, P, Jernberg, T, Hagstrom, E

“…Abstract Background Cardiovascular disease (CVD) risk increases with the level of LDL-cholesterol (LDL-C), and LDL-C lowering treatment improves prognosis…”
Get full text

Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis; a nationwide population-based study by Labaf, Ashkan, Svensson, Peter J, Renlund, Henrik, Jeppsson, Anders, Själander, Anders

“…Background Risk factors of stroke/thromboembolism (TE) and major bleeding, and incidence of these events in specific age categories in warfarin-treated…”
Get full text

Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function by Edfors, Robert, Sahlén, Anders, Szummer, Karolina, Renlund, Henrik, Evans, Marie, Carrero, Juan-Jesus, Spaak, Jonas, James, Stefan K, Lagerqvist, Bo, Varenhorst, Christoph, Jernberg, Tomas

“…We aimed to analyse outcomes of ticagrelor and clopidogrel stratified by estimated glomerular filtration rate (eGFR) in a large unselected cohort of patients…”
Get more information

Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease by Johnston, Nina, MD, PhD, Jönelid, Birgitta, MD, Christersson, Christina, MD, PhD, Kero, Tanja, MD, Renlund, Henrik, PhD, Schenck-Gustafsson, Karin, MD, PhD, Lagerqvist, Bo, MD, PhD

“…The aim of this study was to compare the prognoses of patients with ST-segment elevation myocardial infarction (STEMI) and those with non-ST-segment elevation…”
Get full text

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation by Björck, Fredrik, Renlund, Henrik, Lip, Gregory Y H, Wester, Per, Svensson, Peter J, Själander, Anders

“…Vitamin K antagonist (eg, warfarin) use is nowadays challenged by the non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial…”
Get more information

Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) by Buccheri, Sergio, Sarno, Giovanna, Erlinge, David, Renlund, Henrik, Lagerqvist, Bo, Grimfjärd, Per, Witt, Nils, Yndigegn, Troels, Fröbert, Ole, Persson, Jonas, Böhm, Felix, James, Stefan K

“…The aim of this study was to assess the real-world clinical performance of a sirolimus-eluting ultrathin-strut drug-eluting stent (DES) (Orsiro) in a large…”
Get full text

Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial by Berglund, Erik, Wallentin, Lars, Oldgren, Jonas, Renlund, Henrik, Alexander, John H, Granger, Christopher B, Hohnloser, Stefan H, Hylek, Elaine M, Lopes, Renato D, McMurray, John JV, Lytsy, Per

“…Background A novel approach to determine the effect of a treatment is to calculate the delay of event, which estimates the gain of event-free time. The aim of…”
Get full text

Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study by Nilsson, Konrad, Buccheri, Sergio, Christersson, Christina, Koul, Sasha, Nilsson, Johan, Pétursson, Pétur, Renlund, Henrik, Rück, Andreas, James, Stefan

“…Abstract Aims The aim of this study was to investigate the pattern, causes, and predictors of all new hospitalizations in patients who underwent transcatheter…”
Get full text

Causes, Pattern, Predictors and Prognostic Implications of New Hospitalizations after TAVI: A Long-Term Nationwide Observational Study by Nilsson, K, Buccheri, S, Christersson, C, Koul, S, Nilsson, J, Pétursson, P, Renlund, H, Rück, A, James, S

Get full text

OUTCOMES IN PATIENTS TREATED WITH TICAGRELOR OR CLOPIDOGREL AFTER ACUTE CORONARY SYNDROME: EXPERIENCES FROM SWEDEHEART REGISTRY by Sahlén, Anders, Varenhorst, Christoph, Lagerqvist, Bo, Renlund, Henrik, Omerovic, Elmir, Erlinge, David, Wallentin, Lars, James, Stefan, Jernberg, Tomas

“…The risk of the primary outcome with ticagrelor vs. clopidogrel was 11.7% vs. 22.3% (adjusted hazard ratio (HR) 0.85 [95% confidence interval: 0.78 - 0.93]),…”
Get full text